Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +5.26% and -70.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

As the Oregon National Guard lawsuit proceeds, it’s become clear that right-wing content creators have a direct line to the ...

James Ohlen, of KOTOR and Mass Effect fame, sat down to talk with us about the ongoing Odyssey of the Dragonlords revamp ...

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in ...

(RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a loss of 36 cents per share. The biotechnology company posted revenue of $5.2 ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Reports Q3 revenue $5.2M, consensus $19.36M. Cash, cash equivalents and restricted cash were $667.1M as of September 30, compared to $603.0M as of ...

MT Højgaard Holding releases its interim report for Q3 2025 on 12 November 2025 and hosts a conference call at 10.00 (CET) that date at which the management will present the results and outlook before ...

Previous Community Perspectives have described threats posed by Artificial Intelligence (AI) and its convergence with the rapidly expanding technological ecosystem — especially nanotechnology, ...

Targa Resources Corp. (NYSE: TRGP) ('TRGP,” the 'Company” or 'Targa”) today reported third quarter 2025 results.